- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07588893
Buerger-Allen Exercises and Peripheral Circulation in Sedentary Office Workers (BAE-CIRC)
Acute Effects of Buerger-Allen Exercises on Lower Extremity Circulatory Parameters in Sedentary Office Workers: A Single-Group Pretest-Posttest Clinical Trial
Descripción general del estudio
Estado
Intervención / Tratamiento
Descripción detallada
Sedentary behavior and prolonged sitting are associated with impaired venous return, reduced peripheral blood flow, endothelial dysfunction, and increased cardiovascular risk. Office workers who remain seated for extended periods may experience lower extremity discomfort, edema, and early circulatory impairment.
Buerger-Allen exercises are position-based therapeutic exercises that involve sequential elevation, dependency, and horizontal rest of the lower limbs. These exercises are designed to promote arterial inflow, facilitate venous return, and enhance tissue perfusion without requiring specialized equipment. Previous studies have demonstrated beneficial effects in patients with peripheral vascular disease and diabetes, but evidence regarding their acute effects in healthy sedentary adults is limited.
This study will use a quasi-experimental single-group pretest-posttest design to investigate the immediate effects of Buerger-Allen exercises on lower extremity circulation in sedentary office workers. A total of 35 participants aged 18 to 45 years will be recruited from Istanbul Gelisim University. All participants will complete a standardized 20-minute Buerger-Allen exercise protocol.
Primary outcome measures will include skin surface temperature assessed with infrared thermometry, capillary refill time, ankle-brachial index, peripheral oxygen saturation, and heart rate. Measurements will be performed at baseline, immediately after the intervention, and 10 minutes after the intervention.
The study is expected to provide evidence regarding the effectiveness of a simple and low-cost physiotherapy intervention for improving peripheral circulation and preventing the adverse vascular effects associated with prolonged sedentary behavior.
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Busenur KARAGÖZ, MSc
- Número de teléfono: +90 534 062 71 24
- Correo electrónico: buse.nur97e@gmail.com
Copia de seguridad de contactos de estudio
- Nombre: Gökay ÇAKIROĞLU, PT
- Número de teléfono: +90 542 519 42 55
- Correo electrónico: gcakiroglu@gelisim.edu.tr
Ubicaciones de estudio
-
-
-
Istanbul, Turquía (Türkiye)
- Istanbul Gelisim University
-
Contacto:
- Busenur KARAGÖZ, MSc
- Número de teléfono: +90 534 062 71 24
- Correo electrónico: buse.nur97e@gmail.com
-
Contacto:
- Gökay ÇAKIROĞLU, PT
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
Acepta Voluntarios Saludables
Descripción
Inclusion Criteria:
- Healthy sedentary office workers
- Age between 18 and 45 years
- Sitting for at least 6 hours per day for work-related activities
- Not meeting regular physical activity recommendations
- Willing to participate voluntarily and provide written informed consent
Exclusion Criteria:
- History of peripheral arterial disease, deep vein thrombosis, or other vascular disorders
- Cardiovascular, neurological, or musculoskeletal conditions that may affect lower extremity circulation or prevent exercise participation
- Diabetes mellitus
- Current smoking
- Pregnancy
- Use of medications that may significantly affect peripheral circulation
- Lower extremity injury or surgery within the previous 6 months
- Participation in regular structured exercise programs
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Prevención
- Asignación: N / A
- Modelo Intervencionista: Asignación de un solo grupo
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Buerger-Allen Exercise Group
Participants will perform a single standardized 20-minute Buerger-Allen exercise session.
Lower extremity circulatory parameters will be assessed before the intervention, immediately after the intervention, and 10 minutes after the intervention.
|
The intervention consists of a standardized Buerger-Allen exercise protocol involving three sequential positions: (1) elevation of the lower limbs above heart level to facilitate venous return, (2) dependency of the lower limbs to promote arterial blood flow, and (3) horizontal supine rest to stabilize circulation.
The complete exercise session lasts approximately 20 minutes and is performed once.
Lower extremity circulatory parameters are assessed at baseline, immediately after the intervention, and 10 minutes after the intervention.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Skin Surface Temperature
Periodo de tiempo: Baseline, Immediately After Intervention, and 10 Minutes After Intervention
|
Skin surface temperature measured with an infrared thermometer in degrees Celsius (°C).
Higher values indicate increased peripheral blood flow and tissue perfusion.
|
Baseline, Immediately After Intervention, and 10 Minutes After Intervention
|
|
Capillary Refill Time
Periodo de tiempo: Baseline, Immediately After Intervention, and 10 Minutes After Intervention
|
Capillary refill time measured in seconds.
Shorter times indicate improved peripheral microcirculation and tissue perfusion.
|
Baseline, Immediately After Intervention, and 10 Minutes After Intervention
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Ankle-Brachial Index (ABI)
Periodo de tiempo: Baseline, Immediately After Intervention, and 10 Minutes After Intervention
|
Ratio of ankle to brachial systolic blood pressure used to assess lower extremity arterial circulation.
Higher values within the normal range indicate better arterial perfusion.
|
Baseline, Immediately After Intervention, and 10 Minutes After Intervention
|
|
Peripheral Oxygen Saturation (SpO₂)
Periodo de tiempo: Baseline, Immediately After Intervention, and 10 Minutes After Intervention
|
Oxygen saturation measured by pulse oximetry and expressed as a percentage (%).
Higher values indicate improved peripheral oxygenation.
|
Baseline, Immediately After Intervention, and 10 Minutes After Intervention
|
|
Heart Rate
Periodo de tiempo: Baseline, Immediately After Intervention, and 10 Minutes After Intervention
|
Heart rate measured by pulse oximetry and expressed in beats per minute (bpm).
|
Baseline, Immediately After Intervention, and 10 Minutes After Intervention
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Busenur KARAGÖZ, MSc, Istanbul Gelisim University
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- IGU-FTR-BAE-2026-001
- 2209A-2025Fall-Submitted (Otro identificador: The Scientific and Technological Research Council of Türkiye (TUBITAK))
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .